SOUTH SAN FRANCISCO, Calif., Jan. 12, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 43rd Annual J.P. Morgan Healthcare Conference...
Read More Details
Finally We wish PressBee provided you with enough information of ( IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance )
Also on site :
- The 36 US bases on the frontline of Iranian retribution
- NATO leaders gather Tuesday for what could be a historic summit, or one marred by divisions
- SMB-focused Finom closes €115M as European fintech heats up